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In the first paper of this series (1) it was stated that the precipitin 
index  "offers a  method for the standardization of pneumonia anti- 
body."  In a second paper (2) we concluded that "the ratio precipitin 
index/protective units in monovalent sera was found to lie between 2.8 
and 4.8 for Type I  and to be about ten times greater for Type III." 
The constancy of these quotients is limited by the lack of accuracy in 
the determination of the denominator vi~.. the amount of protective 
units as estimated by the uncertain mouse test. 
The existence of a parallelism of the precipitin with the protective 
antibody in antipneumococcus sera  (2)  was corroborated by Heidel- 
berger, Sia and Kendall (3)  who analysed the maximum specifically 
precipitable protein in their attempts at a quantitative interpretation 
and  explanation  of precipitin phenomena  and  noticed  "a  definite 
parallel  between  maximum  specific  precipitation  in  Type  I  anti- 
pneumococcus  sera and mouse protection." 
The estimation of antipneumococcus antibody by precipitin tests 
has recently been facilitated by the rapid and convenient method pro- 
posed by Zozaya, Boyer and Clark  (4).  As the data of the authors 
mentioned are confined to Type I, and as our previous communication 
dealt with sera against Type I  and III* only, it seemed desirable to 
record data on Type II precipitin and protection tests carried out 
during 1927-1928.  Table I gives the precipitin indices and protective 
* Erroneously quoted as I and II by (3). 
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units for eight Type II horses of the New York City Board of Health 
(Research Laboratories in Otisville, New York).  The  precipitin  in- 
dex was determined as previously described from the average of several 
combinations of antigen and antibody dilutions yielding a perceptible 
specific precipitation.  The mouse protective units in the present as in 
our previous experiments were determined by the testing method of 
TABLE  I 
Comparison of Precipitins and Protective Antibodies in Type II Sera 
No. of  horse  Precipitin  index  Protective  units  Ratio  Duration of  treat-  ment in  months 
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1.4 
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2.3 
Average of last five horses  ...........................  2.1 
+ indicates prozone in precipitin test. 
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the Research Laboratories of the Department of Health of New York 
City. 
The figures in Table I  show (1)  that a similar parallelism holds for 
Type II as for the other types, (2)  that the average ratio of about 2 
is almost half that of Type I.  In other words, in Type II only half the 
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of protective action.  Types II, I and III sera exhibit increasing pre- 
cipitin activity per protective titer in the order named, perhaps due to 
the differences in the equivalent weight of their soluble specific car- 
bohydrates.  (3)  The  previous  observation  was  repeated  that  the 
precipitins reach higher titers at a faster rate than the protective anti- 
bodies during the immunizing treatment.  The subsequent increase 
in protective activity is manifested by the drop of the precipitin/pro- 
tection ratio. 
With due allowance for the irregularities caused by this time factor, 
precipitin methods will provide a practical means for the comparison of 
antisera.  However, some of our concentrated preparations exhibited 
a higher relative precipitin content than original sera (2).  Sabin (5), 
on the other hand, was able to prepare type-specific antibody con- 
centrates, almost or entirely free from precipitin action towards soluble 
specific substance.  Also, Freedlander (6) produced type-specific anti- 
pneumococcus serum of high protective titer devoid  of precipitins. 
It should be emphasized, therefore, that the precipitins do not parallel 
the content of protective antibodies at  all in antibody preparations 
other than unconcentrated horse sera. 
SU'M~A.RY 
The ratio precipitin/protective antibody is  given for several fresh 
antipneumococcus horse sera (Type II). 
The application  of the precipitin test here dealt with and that of 
similar ones, based on the  conception of a  parallelism between pre- 
cipitin and protective antibody, is limited to unrefined horse sera. 
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